Vertex Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
3,900
Employees3,900
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
3,900
Employees3,900

VRTX Key Statistics

Market cap
80.34B
Market cap80.34B
Price-Earnings ratio
24.70
Price-Earnings ratio24.70
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$317.03
High today$317.03
Low today
$312.02
Low today$312.02
Open price
$315.17
Open price$315.17
Volume
713.58K
Volume713.58K
52 Week high
$323.61
52 Week high$323.61
52 Week low
$182.66
52 Week low$182.66

VRTX News

Simply Wall St 2d
Are Robust Financials Driving The Recent Rally In Vertex Pharmaceuticals Incorporated's Stock?

Vertex Pharmaceuticals (NASDAQ:VRTX) has had a great run on the share market with its stock up by a significant 11% over the last three months. Given that the m...

Are Robust Financials Driving The Recent Rally In Vertex Pharmaceuticals Incorporated's Stock?
Benzinga 3d
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,900 Today - Vertex Pharmaceuticals (N - Benzinga

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 12.09% on an annualized basis producing an average annual return of 23.11%. Cu...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,900 Today - Vertex Pharmaceuticals (N - Benzinga
Simply Wall St 6d
Vertex Pharmaceuticals Incorporated Shares Could Be 36% Below Their Intrinsic Value Estimate

Today we will run through one way of estimating the intrinsic value of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by projecting its future cash flows and...

Vertex Pharmaceuticals Incorporated Shares Could Be 36% Below Their Intrinsic Value Estimate

Analyst ratings

64%

of 28 ratings
Buy
64.3%
Hold
35.7%
Sell
0%

VRTX Earnings

$0.00
$1.34
$2.67
$4.01
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Jan 25, After Hours
ActualExpected Jan 25, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.